Close

Articles Posted in Xarelto lawsuit

Updated:

Xarelto Litigation Update

Xarelto (rivaroxaban) is a prescription blood thinner that was developed by pharmaceutical giant Bayer, and marketed by Janssen Pharmaceuticals, a division of another pharmaceutical giant, Johnson & Johnson.  Xarelto is typically prescribed to reduce the risks of suffering a stroke or blood clot in patients who have a heart rhythm…

Contact Us